One Incremental Stride for Doxycycline, One Substantial Advancement for Thyroid Eye Disease.

Authors: Matoc, Ines¹ (AUTHOR) inesmatoc@gmail.com, Kasa, Kim¹ (AUTHOR) kimkasa@yahoo.com, Kasumović, Armin¹ (AUTHOR) kasumovic.armin@gmail.com, Prpić, Ante¹ (AUTHOR) ap.prpic@gmail.com, Vukojević, Ante¹ (AUTHOR) ante.vukojevic1@gmail.com, Zrinšćak, Ognjen¹ (AUTHOR) ozrinscak@yahoo.co.uk, Škunca Herman, Jelena¹ (AUTHOR) blanka.doko.mandic@gmail.com, Doko Mandić, Blanka¹ (AUTHOR) renata.ivekovic@kbcsm.hr, Sabol, Ivan² (AUTHOR) ivan.sabol@irb.hr, Iveković, Renata¹ (AUTHOR) zo.vatavuk@gmail.com, Vatavuk, Zoran¹ (AUTHOR)

Source: Diagnostics (2075-4418). Apr2024, Vol. 14 Issue 8, p791. 12p.

Subject Terms: *DOXYCYCLINE, *THYROID eye disease, *EYE movements, *THYROID diseases, *CLINICAL trials, *RANDOMIZED controlled trials